https://www.selleckchem.com/pr....oducts/poziotinib-hm
s able to appropriately access neuro-ophthalmic care. The survey suggests that neuro-ophthalmologists are unable to see patients in a timely manner and a decreasing number of clinicians are entering the field. Future interventions should be considered to incentivize neuro-ophthalmology training in ophthalmology and neurology residents such that the United States population is able to appropriately access neuro-ophthalmic care. Neurofibromatosis Type 1 (NF-1) is a genetic disease affecting the eye, and ocular findings such a